Establishment Labs Holdings, Inc.

ESTA · NASDAQ

Surgical and Medical Instrument Manufacturing · Costa Rica

Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in more than 80 countries through exclusive distributors or the Company's direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA and initiated the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs' product and technologies portfolio includes the Divina® 3D Simulation System and other products and services.

Market Data

Price $66.35 -2.71 (-3.92%)

Market Cap$2.02B

P/E Ratio—

EPS$—

52W High$83.31

52W Low$26.56

Beta0.95

Data from Finnhub · Updated Mar 11, 2026